Get the tools used by (smart)2 investors.
SP500 -2.0%DOW -1.7%FTSE 100 -0.1%NIKKEI -1.0%OIL -0.9%GOLD 0.7%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Price / LTM FCF for ANI Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ANIP: ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides i...

67.61 USD
Price
– USD
Fair Value
–
Upside
52.50 - 70.05
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on ANI Pharmaceuticals Inc's Price / LTM FCF:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0x50.0x100.0x150.0x
Performance Summary
  • ANI Pharmaceuticals's latest twelve months price / ltm fcf is 28.7x
  • ANI Pharmaceuticals's price / ltm fcf for fiscal years ending December 2020 to 2024 averaged 37.9x.
  • ANI Pharmaceuticals's operated at median price / ltm fcf of 17.5x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, ANI Pharmaceuticals's price / ltm fcf peaked in December 2021 at 140.6x.
  • ANI Pharmaceuticals's price / ltm fcf hit its 5-year low in December 2022 of -14.5x.
  • ANI Pharmaceuticals's price / ltm fcf decreased in 2022 (-14.5x, -110.3%) and increased in 2020 (17.4x, +47.2%), 2021 (140.6x, +709.3%), 2023 (17.5x, -220.4%), and 2024 (28.7x, +64.1%).

Benchmarks

Metric Usage: Price / LTM FCF

Hide this widget
price_to_fcf_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Price / LTM FCF in the valuation category include:

  • Share Turnover Ratio - This item represents three-month average volume divided by the shares outstanding for a company
  • Cost of Equity - Our estimate of the rate of return required by equity holders.
  • EV / Revenue - Measures the dollars in Enterprise Value for each dollar of revenue over the last twelve months.
  • Price / LTM FCF - Measures the ratio of a stock's price to its levered free cash flow per share.
View Full List

Search for metric or datapoint

Price / LTM FCF

Measures the ratio of a stock's price to its levered free cash flow per share.

Definition of Price / LTM FCF

Hide this widget
Measures the ratio of a stock's price to its levered free cash flow per share.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-138.6x-68.6x1.4x138.6x0200400600

The chart above depicts the distribution of price / ltm fcf for companies operating in the Healthcare sector in the Developed economic region. Over 1,970 companies were considered in this analysis, and 1,896 had meaningful values. The average price / ltm fcf of companies in the sector is 0.1x with a standard deviation of 23.5x.

ANI Pharmaceuticals Inc's Price / LTM FCF of 28.7x ranks in the 91.9% percentile for the sector. The following table provides additional summary stats:

Price / LTM FCF In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,976
Included Constituents1,896
Min-138.0x
Max132.4x
Median-1.1x
Mean0.1x
Standard Deviation23.5x

You can find companies with similar price / ltm fcf using this stock screener.

All rights reserved. Terms Of Use